Heat-shock proteins protect cells from monocyte cytotoxicity: possible mechanism of self-protection

We have previously shown that major heat-shock protein (hsp 70) protects WEHI-S tumor cells from cytotoxicity mediated by tumor necrosis factor alpha (TNF-alpha) and TNF-beta. In the present study, the effect of altered expression of hsp70 and low molecular weight heat- shock protein, hsp27, on tumor cell sensitivity to monocytes and lymphokine-activated killer (LAK) cells was studied. Constitutive and stable expression of transfected human hsp70 rendered cells almost completely resistant to monocytes. Conversely, inhibition of endogenous hsp70 by expression of antisense hsp70 RNA enhanced the sensitivity of cells to monocyte-mediated killing. Surprisingly, overexpression of human hsp27, which does not protect WEHI-S cells from TNF killing, conferred partial resistance to monocytes. Only approximately 60% of monocyte-mediated killing of WEHI-S cells could be blocked by neutralizing TNF-alpha antibody or immunoglobulin G-TNF receptor chimeric protein, suggesting the presence of both TNF-dependent and TNF- independent lytic mechanisms. As free radicals have been suggested to be mediators of monocyte cytotoxicity, we tested the sensitivity of transfected cells to oxidative stress. Overexpression of either hsp70 or hsp27 rendered cells partially resistant to hydrogen peroxide. No significant changes in the susceptibility of cell lines overexpressing hsp70 or hsp27 to cytotoxicity mediated by LAK cells were observed. Interestingly, monocytes but not LAK cells contained detectable levels of hsp27 and hsp70 in nonstressed conditions. Taken together, these data indicate that hsp70 protects tumor cells from TNF-mediated monocyte cytotoxicity and that both hsp27 and hsp70 confer resistance to TNF-independent, probably free radical-mediated lysis by monocytes. Moreover, hsp27 and hsp70 may provide monocytes with a protective mechanism against their own toxicity.

[1]  G. Li,et al.  Thermal response of rat fibroblasts stably transfected with the human 70-kDa heat shock protein-encoding gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Rossi,et al.  Use of polymerase chain reaction to detect the expression of the Mr 70,000 heat shock genes in control or heat shock leukemic cells as correlated to their heat response. , 1990, Cancer Research.

[3]  G. Riethmüller,et al.  A rapid assay for cytotoxicity of unstimulated human monocytes. , 1984, Journal of the National Cancer Institute.

[4]  W. McGuire,et al.  Induction of the estrogen-regulated "24K" protein by heat shock. , 1989, Cancer research.

[5]  C. Janeway,et al.  Elevated temperature regulates tumor necrosis factor‐mediated immune killing , 1989, European journal of immunology.

[6]  J. Landry,et al.  Prognostic influence of HSP-27 expression in malignant fibrous histiocytoma: a clinicopathological and immunohistochemical study. , 1992, Cancer research.

[7]  M. Jäättelä,et al.  Emerging role of heat shock proteins in biology and medicine. , 1992, Annals of medicine.

[8]  E. Saksela,et al.  Fractionation, morphological and functional characterization of effector cells responsible for human natural killer activity against cell-line targets. , 1979, Cellular immunology.

[9]  J. Landry,et al.  Heat shock resistance conferred by expression of the human HSP27 gene in rodent cells , 1989, The Journal of cell biology.

[10]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[11]  R L Kassel,et al.  An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Jäättelä,et al.  Heat shock protects WEHI‐164 target cells from the cytolysis by tumor necrosis factors α and β , 1989 .

[13]  J. D. Young,et al.  Multiple mechanisms of lymphocyte-mediated killing. , 1988, Immunology today.

[14]  C. Benz,et al.  Stress response protein (srp-27) determination in primary human breast carcinomas: clinical, histologic, and prognostic correlations. , 1991, Journal of the National Cancer Institute.

[15]  C. Nathan,et al.  Molecular mechanisms in tumor-cell killing by activated macrophages. , 1983, Immunology today.

[16]  B. Beutler,et al.  A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity , 1991, The Journal of experimental medicine.

[17]  M. Jäättelä,et al.  Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity. , 1992, The EMBO journal.